Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations

NCT03229668 — Phase 2 / Phase 3, Completed, 78 participants, Saint Savvas Anticancer Hospital

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03229668
StatusCompleted
PhasePhase 2 / Phase 3
Study typeInterventional; randomized, parallel, masking: quadruple, prevention
Enrollment78 (Actual)
SponsorSaint Savvas Anticancer Hospital (Other); collaborators: University of Thessaly
ConditionsPregabalin on Catheter Related Bladder Discomfort
InterventionsPlacebo oral capsule, Pregabalin Oral Capsule [Lyrica] 75mg, Pregabalin Oral Capsule [Lyrica] 150 mg (Drug)
Datesstart 2017-07-28, primary completion 2019-12-31, completion 2020-02-20, first posted 2017-07-25, last updated 2026-10-15
Locations2 sites in Greece

Related Papers Related Patents Related Grants Related Experts
All trials for Pregabalin on Catheter Related Bladder Discomfort All trials of Placebo oral capsule All trials of Pregabalin Oral Capsule [Lyrica] 75mg

-Summary

The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to urological operations because of the high incidence of CRBD observed in this kind of surgical population.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Group IPlacebo comparatorDrug: Placebo oral capsuleAdministration of a placebo capsule 1 hour prior to the surgical operation
Group IIExperimentalDrug: Pregabalin Oral Capsule [Lyrica] 75mgAdministration of 75mg of pregabalin 1 hour prior to the surgical operation
Group IIIExperimentalDrug: Pregabalin Oral Capsule [Lyrica] 150 mgAdministration of 150mg of pregabalin 1 hour prior to the surgical operation
  • Placebo oral capsule (Drug): Placebo oral capsule administered 1 hour prior to the surgical operation
  • Pregabalin Oral Capsule [Lyrica] 75mg (Drug), also known as Pregabalin: Pregabalin Oral Capsule \[Lyrica\] 75 mg administered 1 hour prior to the surgical operation
  • Pregabalin Oral Capsule [Lyrica] 150 mg (Drug), also known as Pregabalin: Pregabalin Oral Capsule \[Lyrica\] 150 mg administered 1 hour prior to the surgical operation

+Outcome measures

Primary outcomes

  • Percentage of postsurgical catheter-related bladder discomfort after preoperative pregabalin administration [Change from preoperative status to postoperative one at 0, 1, 2, 6, 24 hours postoperatively]: Assessment of discomfort will be made by a scale of four (1=no discomfort, 2=mild discomfort reported on questioning only, 3=moderate discomfort, urge to pass urine reported by the patient without questioning, 4= severe discomfort, urge to pass urine accompanied by behavioral responses, such as flailing limbs, strong vocal responses or attempts to pull the catheter out)

Secondary outcomes

  • Postoperative pain assessed by NPRS scale (Numeric Pain Rating Scale) [Total amount of tramadol administered in the first 24 hours postoperatively]: The goal is to achieve pain scores<3 as these are assessed by the NPRS scale. In order to achieve that we will record the total amount of tramadol milligrams administered in the first 24 hours postoperatively
  • Adverse effects of the drug [All adverse effects observed in the first 24 hours postoperatively]: Postoperative nausea and vomiting, confusion, vertigo, blurred vision, dry mouth,sedation, dizziness
  • Assessment of postoperative sedation [In the operating theatre immediately after patient's extubation]: The Ramsay Sedation Scale is used to measure different levels of sedation in medical patients (1=Patient is anxious and agitated or restless, or both 2=Patient is co-operative, oriented, and tranquil, 3=Patient responds to commands only, 4=Patient exhibits brisk response to light glabellar tap or loud auditory stimulus, 5=Patient exhibits a sluggish response to light glabellar tap or loud auditory stimulus, 6=Patient exhibits no response)

+Eligibility

Sex: All, ages: 45 Years to 85 Years

Inclusion Criteria:

* All patients about to be subjected to urinary operations
* Signed informed consent

Exclusion Criteria:

* Preoperative urinary bladder/kidney dysfunction as a result of spinal cord pathology
* History of overactive ((urinary frequency>3 times at night and >8 times in 24 hours), neurogenic bladder
* End stage renal failure
* Central nervous system dysfunction
* Mental illness/ substance abuse
* Sensitivity to pregabalin
* Preoperative administration of pregabalin for other indications
* Recent bladder catheterization <3 months

+Locations (2)

FacilityCityCountryStatus
Anticancer Hospital of Athens "Saint Savvas"AthensGreece
University of Thessaly, Medical SchoolVolosGreece

+Publications

  • Agarwal A, Dhiraaj S, Singhal V, Kapoor R, Tandon M. Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth. 2006 Mar;96(3):377-80. doi: 10.1093/bja/ael003. Epub 2006 Jan 16. PMID 16415311
  • Srivastava VK, Agrawal S, Kadiyala VN, Ahmed M, Sharma S, Kumar R. The efficacy of pregabalin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled double-blind study. J Anesth. 2015 Apr;29(2):212-6. doi: 10.1007/s00540-014-1911-x. Epub 2014 Sep 9. PMID 25200037
  • Tauzin-Fin P, Stecken L, Sztark F. [Catheter-related bladder discomfort in post-anaesthesia care unit]. Ann Fr Anesth Reanim. 2012 Jul-Aug;31(7-8):605-8. doi: 10.1016/j.annfar.2012.03.009. Epub 2012 Jun 29. French. PMID 22749555
  • Bai Y, Wang X, Li X, Pu C, Yuan H, Tang Y, Li J, Wei Q, Han P. Management of Catheter-Related Bladder Discomfort in Patients Who Underwent Elective Surgery. J Endourol. 2015 Jun;29(6):640-9. doi: 10.1089/end.2014.0670. Epub 2014 Dec 9. PMID 25335575
  • Ryu JH, Hwang JW, Lee JW, Seo JH, Park HP, Oh AY, Jeon YT, Do SH. Efficacy of butylscopolamine for the treatment of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study. Br J Anaesth. 2013 Dec;111(6):932-7. doi: 10.1093/bja/aet249. Epub 2013 Jul 17. PMID 23869107
  • Agarwal A, Gupta D, Kumar M, Dhiraaj S, Tandon M, Singh PK. Ketamine for treatment of catheter related bladder discomfort: a prospective, randomized, placebo controlled and double blind study. Br J Anaesth. 2006 May;96(5):587-9. doi: 10.1093/bja/ael048. Epub 2006 Mar 10. PMID 16531445
  • Agarwal A, Yadav G, Gupta D, Singh PK, Singh U. Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth. 2008 Oct;101(4):506-10. doi: 10.1093/bja/aen217. Epub 2008 Jul 24. PMID 18653496
  • Nam K, Seo JH, Ryu JH, Oh AY, Lee T, Park HP, Jeon YT, Hwang JW. Randomized, clinical trial on the preventive effects of butylscopolamine on early postoperative catheter-related bladder discomfort. Surgery. 2015 Feb;157(2):396-401. doi: 10.1016/j.surg.2014.05.017. Epub 2014 Oct 8. PMID 25304838

+Investigators